The Role of Venlafaxine in the Treatment of Obsessive—Compulsive Disorder

@article{Phelps2005TheRO,
  title={The Role of Venlafaxine in the Treatment of Obsessive—Compulsive Disorder},
  author={Nicole Phelps and Marshall E. Cates},
  journal={Annals of Pharmacotherapy},
  year={2005},
  volume={39},
  pages={136 - 140}
}
  • N. Phelps, M. Cates
  • Published 1 January 2005
  • Psychology, Medicine
  • Annals of Pharmacotherapy
OBJECTIVE: To evaluate the published literature regarding the use of venlafaxine in the treatment of obsessive—compulsive disorder (OCD). DATA SOURCES: MEDLINE (1996–March 2004) and International Pharmaceutical Abstracts (1970–March 2004) were searched using the terms venlafaxine and obsessive—compulsive disorder. A bibliographic search was conducted as well. DATA SYNTHESIS: Successful treatment of OCD with venlafaxine has been reported in case reports, open trials, and blinded trials versus… 
View on SAGE
ncbi.nlm.nih.gov
18 Citations
Background Citations
5

Tables from this paper

18 Citations

Citation Type

Citation Type

An emerging role for escitalopram in the treatment of obsessive-compulsive disorder
TLDR
Enantiomeric specificity, high serotonin reuptake selectivity, comparatively good tolerability and favorable pharmacokinetics, and preliminary evidence of efficacy in OCD suggest a potential role for the use of escitalopram in the treatment of OCD.
COMBINATION OF CITALOPRAM AND NORTRIPTYLINE IN THE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER: A DOUBLE – BLIND, PLACEBO-CONTROLLED TRIAL
Objective: The fact that some antidepressants with strong effects on serotonin reuptake blockade fail to relieve obsessive-compulsive symptoms has caused growing interest in investigating…
Citalopram and Nortriptyline in OCD Combination of Citalopram and Nortriptyline in the Treatment of Obsessive-Compulsive Disorder : A Double – Blind , Placebo-Controlled Trial
TLDR
This study indicates that nortriptyline improves the efficacy of citalopram, and supports further investigation of the noradrenergic– serotonergic hypothesis in OCD.
Current management of obsessive and phobic states
TLDR
The clinical and psychological features likely to characterize patients refractory to treatment for obsessive-compulsive disorder are described, with the aim of highlighting the need for greater attention to more patient-oriented management of the disease.
Treating refractory obsessive-compulsive disorder: what to do when conventional treatment fails?
TLDR
Clinicians dealing with refractory OCD patients should review intrinsic phenomenological aspects of OCD, which could lead to different interpretations and treatment choices and consider non-conventional pharmacological approaches and neurobiological approaches.
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder
The psychopharmacology algorithm project at the Harvard South Shore Program: An algorithm for adults with obsessive-compulsive disorder
Glutamatergic dysfunction in obsessive-compulsive disorder and the potential clinical utility of glutamate-modulating agents
Obsessive-compulsive disorder (OCD) is a common psychiatric disorder and the tenth leading cause of disability in the world. The introduction of serotonin reuptake inhibitors (SRIs) in the 1980s…
Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
  • D. Denys
  • Psychology, Medicine
    The Psychiatric clinics of North America
  • 2006
Neurobiology and Pharmacotherapy of Obsessive-Compulsive Disorder
TLDR
While classified as an anxiety disorder in DSM-IV, OCD is given a separate chapter here as the clinical phenomenology, drug treatment response, family studies, and brain imaging data support a separate neurobiological classification for this disorder.
...
1
2
...

References

SHOWING 1-10 OF 24 REFERENCES
Venlafaxine in obsessive-compulsive disorder.
In a contribution to the January 1995 issue of the Archives comparing the efficacy and tolerability of clomipramine, fluoxetine, fluvoxamine, and sertraline, Greist et al, 1 using a method of…
A Double Blind Comparison of Venlafaxine and Paroxetine in Obsessive-Compulsive Disorder
TLDR
Results show that venlafaxine was equally effective to paroxetine in treating patients with OCD, and may be a useful therapy for obsessive-compulsive patients, but is not superior to SSRIs.
Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.
TLDR
It is indicated that venlafaxine might be as efficacious as clomipramine in the acute treatment of OCD, with fewer side effects.
A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder
TLDR
The serotonin reuptake inhibitors, including clomipramine, fluvoxamine, fluoxetine, sertraline, and paroxetines, have been approved by the U.S. Food and Drug Administration for the treatment of adults with obsessive-compulsive disorder.
A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.
TLDR
The first double-blind switch study of 2 SRIs in patients with OCD shows that 42% of the nonresponders benefited from a crossover to the other SRI, and that paroxetine was more efficacious than venlafaxine in the treatment of non responders to a previous SRI trial.
Pharmacotherapy of Obsessive‐Compulsive Disorder
TLDR
Clomipramine, a tricyclic antidepressant, appears to be the most promising therapy in OCD, and other serotonergic agents such as fluoxetine have shown promise, but they have been studied only in a limited number of patients.
Obsessive-compulsive disorder: diagnosis and treatment.
  • W. Goodman
  • Psychology, Medicine
    The Journal of clinical psychiatry
  • 1999
TLDR
Guidelines for the use of SSRIs and novel approaches for managing treatment-refractory patients are discussed and effective alternatives include switching to a different SSRI, combining another medication or behavioral therapy with SSRI therapy, and employing novel or experimental drug treatments.
Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients.
  • M. Thase
  • Medicine, Psychology
    The Journal of clinical psychiatry
  • 1998
TLDR
Concern about blood pressure effects should not deter first-line use of this effective antidepressant, although more extensive studies of patients with cardiovascular diseases are still necessary.
Managing the patient with treatment-resistant obsessive compulsive disorder: current strategies.
TLDR
While researchers are seeking more effective treatments and a clearer understanding of the pathophysiology of obsessive compulsive disorder, it is important for clinicians to optimally utilize the tools currently available.
SSRIs and SNRIs: broad spectrum of efficacy beyond major depression.
TLDR
These new antidepressants, because of their specificity for the serotonin and norepinephrine reuptake proteins, lack most of the adverse side effects of tricyclic antidepressants and monoamine oxidase inhibitors, and are also first-line for panic disorder, obsessive-compulsive disorder, social phobia, posttraumatic stress disorder, and bulimia.
...
1
2
3
...